Thursday, June 25, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 864 of 1,261

  1. US 8481738

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  2. US 8481578

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  3. US 8481760

    Inhibition and treatment of prostate cancer metastasis

    Northwestern University · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  4. US 8480995

    Use of sodium selenosulfate for supplementing selenium and enhancing the therapeutic efficacy of chemotherapy agents, and a rapid process for preparing sodium selenosulfate

    UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  5. US 8481024

    Vaccines against tularemia

    The Regents of the University of California · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  6. US 8481757

    Compounds and compositions useful in the treatment of malaria

    The Regents of the University of California · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  7. US 8481569

    Iminopyridine derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  8. US 8481551

    Gyrase and topoisomerase IV inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  9. US 8481035

    Methods for treating chronic pelvic pain syndrome with antibodies that binds MCP-1 or MIP-1A

    Northwestern University · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  10. MX 2013000877

    APPLICATION OF β-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT.

    BIOLITEC PHARMA MARKETING LTD [MY] · Granted Jul 3, 2013 · Expires Jun 28, 2033

    granted

  11. US 8476236

    Treatment of skin conditions by Dickkopf1 (DKK1)

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 2, 2013 · Expires Jun 27, 2033

    granted

  12. US 8476451

    Tubulysin D analogues

    The Regents of the University of California · Granted Jul 2, 2013 · Expires Jun 27, 2033

    granted

  13. US 8475792

    Molecules with extended half-lives, compositions and uses thereof

    Board of Regents, The Texas University System · Granted Jul 2, 2013 · Expires Jun 27, 2033

    granted

  14. US 8476299

    Crystalline form of a biphenyl compound

    Theravance, Inc. · Granted Jul 2, 2013 · Expires Jun 27, 2033

    granted

  15. US 8476254

    Methods for treating psychosis associated with interferson-α therapy

    Corcept Therapeutics Incorporated · Granted Jul 2, 2013 · Expires Jun 27, 2033

    granted

  16. US 8476442

    Process for making modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Jul 2, 2013 · Expires Jun 27, 2033

    granted

  17. US 8476043

    Inhibitors for the soluble epoxide hydrolase

    The Regents of the University of California · Granted Jul 2, 2013 · Expires Jun 27, 2033

    granted

  18. US 8476413

    Sulfanyl-tetrahydropyran-based compounds and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Jul 2, 2013 · Expires Jun 27, 2033

    granted

  19. US 8475764

    Labelled adrenomedullin derivatives and their use for imaging and therapy

    INSTITUT DE CARDIOLOGIE DE MONTREAL · Granted Jul 2, 2013 · Expires Jun 27, 2033

    granted

  20. US 8474529

    Control of concentric tubing direction

    Regency Technologies LLC · Granted Jul 2, 2013 · Expires Jun 27, 2033

    granted

  21. US 8475828

    Medical apparatus and method for producing same

    Covidien LP · Granted Jul 2, 2013 · Expires Jun 27, 2033

    granted

  22. US 8476229

    Blood sugar-modulating polypeptides

    China Medical University · Granted Jul 2, 2013 · Expires Jun 27, 2033

    granted

  23. US 8476263

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Jul 2, 2013 · Expires Jun 27, 2033

    granted

  24. US 8476338

    Dental curable composition and composite resin using the same

    KURARAY NORITAKE DENTAL INC. · Granted Jul 2, 2013 · Expires Jun 27, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.